Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases

Among other non-antibiotic properties, tetracyclines inhibit matrix metalloproteinases and are currently under study for the treatment of osteoarthritis. Quaternary ammonium conjugates of tetracyclines were synthesized by direct alkylation of the amine function at the 4-position with methyl iodide....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2007-03, Vol.15 (6), p.2368-2374
Hauptverfasser: Vidal, Aurélien, Sabatini, Massimo, Rolland-Valognes, Gaëlle, Renard, Pierre, Madelmont, Jean-Claude, Mounetou, Emmanuelle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2374
container_issue 6
container_start_page 2368
container_title Bioorganic & medicinal chemistry
container_volume 15
creator Vidal, Aurélien
Sabatini, Massimo
Rolland-Valognes, Gaëlle
Renard, Pierre
Madelmont, Jean-Claude
Mounetou, Emmanuelle
description Among other non-antibiotic properties, tetracyclines inhibit matrix metalloproteinases and are currently under study for the treatment of osteoarthritis. Quaternary ammonium conjugates of tetracyclines were synthesized by direct alkylation of the amine function at the 4-position with methyl iodide. When tested in vitro, they inhibited cytokine-induced MMP expression to a lesser extent than parent tetracyclines. This was compensated by an improved inhibition of MMP catalytic activity. Since inhibition of collagen degradation was maintained these derivatives could be potent drug candidates for cartilage-targeted chondroprotective treatment.
doi_str_mv 10.1016/j.bmc.2007.01.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69016529</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089607000351</els_id><sourcerecordid>69016529</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-b779a2c298897ae860201d7ebe5921d3657eb0e2bec0e792993c9bbffe5fbc7f3</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EotvCD-gF-QK3BNvZ2DGcUNUPpEocaM-W7UzaWSVOsb0Ry6_Hq92qt55mDs_7zugh5JyzmjMuv25qN_laMKZqxmsm5Buy4mu5rppG87dkxbTsKtZpeUJOU9owxsRa8_fkhCshlRBqRf793oX8CAkTtaGnGOiCOc4UFjtubcY50Hmg2cYHyNDTDDlav_MjBqA9RFwKs0D6Ri-HAXxOtAQwPKLD5-xkc8S_dIJsx3F-inMGDDZB-kDeDXZM8PE4z8j91eXdxU11--v658WP28o3Hc-VU0pb4YXuOq0sdJIJxnsFDloteN_ItuwMhAPPQGmhdeO1c-WddnBeDc0Z-XLoLbf_bCFlM2HyMI42wLxNRurishW6gPwA-jinFGEwTxEnG3eGM7MXbjamCDd74YZxU4SXzKdj-dZN0L8kjoYL8PkI2OTtOEQbPKYXrmsbrfW-6PuBg6JiQYgmeYTgocdYxJp-xlfe-A-5J6Fl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69016529</pqid></control><display><type>article</type><title>Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vidal, Aurélien ; Sabatini, Massimo ; Rolland-Valognes, Gaëlle ; Renard, Pierre ; Madelmont, Jean-Claude ; Mounetou, Emmanuelle</creator><creatorcontrib>Vidal, Aurélien ; Sabatini, Massimo ; Rolland-Valognes, Gaëlle ; Renard, Pierre ; Madelmont, Jean-Claude ; Mounetou, Emmanuelle</creatorcontrib><description>Among other non-antibiotic properties, tetracyclines inhibit matrix metalloproteinases and are currently under study for the treatment of osteoarthritis. Quaternary ammonium conjugates of tetracyclines were synthesized by direct alkylation of the amine function at the 4-position with methyl iodide. When tested in vitro, they inhibited cytokine-induced MMP expression to a lesser extent than parent tetracyclines. This was compensated by an improved inhibition of MMP catalytic activity. Since inhibition of collagen degradation was maintained these derivatives could be potent drug candidates for cartilage-targeted chondroprotective treatment.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2007.01.026</identifier><identifier>PMID: 17267227</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cartilage, Articular - drug effects ; Cartilage, Articular - enzymology ; Chondrosarcoma - drug therapy ; Chondrosarcoma - enzymology ; Chondrosarcoma - pathology ; Collagen - drug effects ; Collagen - metabolism ; Humans ; In Vitro Techniques ; Matrix Metalloproteinase Inhibitors ; Matrix Metalloproteinases - metabolism ; Medical sciences ; Metalloproteinases ; Osteoarthritis ; Pharmacology. Drug treatments ; Protease Inhibitors - chemical synthesis ; Protease Inhibitors - chemistry ; Protease Inhibitors - pharmacology ; Proteoglycans - drug effects ; Proteoglycans - metabolism ; Quaternary ammonium ; Rabbits ; Tetracyclines ; Tetracyclines - chemical synthesis ; Tetracyclines - chemistry ; Tetracyclines - pharmacology</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2007-03, Vol.15 (6), p.2368-2374</ispartof><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-b779a2c298897ae860201d7ebe5921d3657eb0e2bec0e792993c9bbffe5fbc7f3</citedby><cites>FETCH-LOGICAL-c381t-b779a2c298897ae860201d7ebe5921d3657eb0e2bec0e792993c9bbffe5fbc7f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089607000351$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18539996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17267227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vidal, Aurélien</creatorcontrib><creatorcontrib>Sabatini, Massimo</creatorcontrib><creatorcontrib>Rolland-Valognes, Gaëlle</creatorcontrib><creatorcontrib>Renard, Pierre</creatorcontrib><creatorcontrib>Madelmont, Jean-Claude</creatorcontrib><creatorcontrib>Mounetou, Emmanuelle</creatorcontrib><title>Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Among other non-antibiotic properties, tetracyclines inhibit matrix metalloproteinases and are currently under study for the treatment of osteoarthritis. Quaternary ammonium conjugates of tetracyclines were synthesized by direct alkylation of the amine function at the 4-position with methyl iodide. When tested in vitro, they inhibited cytokine-induced MMP expression to a lesser extent than parent tetracyclines. This was compensated by an improved inhibition of MMP catalytic activity. Since inhibition of collagen degradation was maintained these derivatives could be potent drug candidates for cartilage-targeted chondroprotective treatment.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cartilage, Articular - drug effects</subject><subject>Cartilage, Articular - enzymology</subject><subject>Chondrosarcoma - drug therapy</subject><subject>Chondrosarcoma - enzymology</subject><subject>Chondrosarcoma - pathology</subject><subject>Collagen - drug effects</subject><subject>Collagen - metabolism</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Matrix Metalloproteinase Inhibitors</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>Medical sciences</subject><subject>Metalloproteinases</subject><subject>Osteoarthritis</subject><subject>Pharmacology. Drug treatments</subject><subject>Protease Inhibitors - chemical synthesis</subject><subject>Protease Inhibitors - chemistry</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Proteoglycans - drug effects</subject><subject>Proteoglycans - metabolism</subject><subject>Quaternary ammonium</subject><subject>Rabbits</subject><subject>Tetracyclines</subject><subject>Tetracyclines - chemical synthesis</subject><subject>Tetracyclines - chemistry</subject><subject>Tetracyclines - pharmacology</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EotvCD-gF-QK3BNvZ2DGcUNUPpEocaM-W7UzaWSVOsb0Ry6_Hq92qt55mDs_7zugh5JyzmjMuv25qN_laMKZqxmsm5Buy4mu5rppG87dkxbTsKtZpeUJOU9owxsRa8_fkhCshlRBqRf793oX8CAkTtaGnGOiCOc4UFjtubcY50Hmg2cYHyNDTDDlav_MjBqA9RFwKs0D6Ri-HAXxOtAQwPKLD5-xkc8S_dIJsx3F-inMGDDZB-kDeDXZM8PE4z8j91eXdxU11--v658WP28o3Hc-VU0pb4YXuOq0sdJIJxnsFDloteN_ItuwMhAPPQGmhdeO1c-WddnBeDc0Z-XLoLbf_bCFlM2HyMI42wLxNRurishW6gPwA-jinFGEwTxEnG3eGM7MXbjamCDd74YZxU4SXzKdj-dZN0L8kjoYL8PkI2OTtOEQbPKYXrmsbrfW-6PuBg6JiQYgmeYTgocdYxJp-xlfe-A-5J6Fl</recordid><startdate>20070315</startdate><enddate>20070315</enddate><creator>Vidal, Aurélien</creator><creator>Sabatini, Massimo</creator><creator>Rolland-Valognes, Gaëlle</creator><creator>Renard, Pierre</creator><creator>Madelmont, Jean-Claude</creator><creator>Mounetou, Emmanuelle</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070315</creationdate><title>Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases</title><author>Vidal, Aurélien ; Sabatini, Massimo ; Rolland-Valognes, Gaëlle ; Renard, Pierre ; Madelmont, Jean-Claude ; Mounetou, Emmanuelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-b779a2c298897ae860201d7ebe5921d3657eb0e2bec0e792993c9bbffe5fbc7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cartilage, Articular - drug effects</topic><topic>Cartilage, Articular - enzymology</topic><topic>Chondrosarcoma - drug therapy</topic><topic>Chondrosarcoma - enzymology</topic><topic>Chondrosarcoma - pathology</topic><topic>Collagen - drug effects</topic><topic>Collagen - metabolism</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Matrix Metalloproteinase Inhibitors</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>Medical sciences</topic><topic>Metalloproteinases</topic><topic>Osteoarthritis</topic><topic>Pharmacology. Drug treatments</topic><topic>Protease Inhibitors - chemical synthesis</topic><topic>Protease Inhibitors - chemistry</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Proteoglycans - drug effects</topic><topic>Proteoglycans - metabolism</topic><topic>Quaternary ammonium</topic><topic>Rabbits</topic><topic>Tetracyclines</topic><topic>Tetracyclines - chemical synthesis</topic><topic>Tetracyclines - chemistry</topic><topic>Tetracyclines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vidal, Aurélien</creatorcontrib><creatorcontrib>Sabatini, Massimo</creatorcontrib><creatorcontrib>Rolland-Valognes, Gaëlle</creatorcontrib><creatorcontrib>Renard, Pierre</creatorcontrib><creatorcontrib>Madelmont, Jean-Claude</creatorcontrib><creatorcontrib>Mounetou, Emmanuelle</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vidal, Aurélien</au><au>Sabatini, Massimo</au><au>Rolland-Valognes, Gaëlle</au><au>Renard, Pierre</au><au>Madelmont, Jean-Claude</au><au>Mounetou, Emmanuelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2007-03-15</date><risdate>2007</risdate><volume>15</volume><issue>6</issue><spage>2368</spage><epage>2374</epage><pages>2368-2374</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Among other non-antibiotic properties, tetracyclines inhibit matrix metalloproteinases and are currently under study for the treatment of osteoarthritis. Quaternary ammonium conjugates of tetracyclines were synthesized by direct alkylation of the amine function at the 4-position with methyl iodide. When tested in vitro, they inhibited cytokine-induced MMP expression to a lesser extent than parent tetracyclines. This was compensated by an improved inhibition of MMP catalytic activity. Since inhibition of collagen degradation was maintained these derivatives could be potent drug candidates for cartilage-targeted chondroprotective treatment.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17267227</pmid><doi>10.1016/j.bmc.2007.01.026</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2007-03, Vol.15 (6), p.2368-2374
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_69016529
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Cartilage, Articular - drug effects
Cartilage, Articular - enzymology
Chondrosarcoma - drug therapy
Chondrosarcoma - enzymology
Chondrosarcoma - pathology
Collagen - drug effects
Collagen - metabolism
Humans
In Vitro Techniques
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases - metabolism
Medical sciences
Metalloproteinases
Osteoarthritis
Pharmacology. Drug treatments
Protease Inhibitors - chemical synthesis
Protease Inhibitors - chemistry
Protease Inhibitors - pharmacology
Proteoglycans - drug effects
Proteoglycans - metabolism
Quaternary ammonium
Rabbits
Tetracyclines
Tetracyclines - chemical synthesis
Tetracyclines - chemistry
Tetracyclines - pharmacology
title Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A18%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20in%20vitro%20evaluation%20of%20targeted%20tetracycline%20derivatives:%20Effects%20on%20inhibition%20of%20matrix%20metalloproteinases&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Vidal,%20Aur%C3%A9lien&rft.date=2007-03-15&rft.volume=15&rft.issue=6&rft.spage=2368&rft.epage=2374&rft.pages=2368-2374&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2007.01.026&rft_dat=%3Cproquest_cross%3E69016529%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69016529&rft_id=info:pmid/17267227&rft_els_id=S0968089607000351&rfr_iscdi=true